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Abstract
Polymer hydrogels are widely used as cell scaffolds for biomedical applications. While the 
biochemical and biophysical properties of hydrogels have been extensively investigated, little 
attention has been paid to their potential photonic functionalities. Here, we report cell-integrated 
polyethylene glycol-based hydrogels for in-vivo optical sensing and therapy applications. 
Hydrogel patches containing cells were implanted in awake, freely moving mice for several days 
and shown to offer long-term transparency, biocompatibility, cell-viability, and light-guiding 
properties (loss: <1 dB/cm). Using optogenetic, glucagon-like peptide-1 (GLP-1) secreting cells, 
we conducted light-controlled therapy using the hydrogel in a mouse model with type-2 diabetes 
and attained improved glucose homeostasis. Furthermore, real-time optical readout of 
encapsulated heat-shock-protein-coupled fluorescent reporter cells made it possible to measure the 
nanotoxicity of cadmium-based bare and shelled quantum dots (CdTe; CdSe/ZnS) in vivo.
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As the autonomous building block of the body, cells have amazing abilities to sense their 
local environment and respond to external chemical and physical cues1. In addition, cells 
secret cytokines and hormones that are critical for homeostasis and also useful for 
therapeutic purposes2. There have been considerable efforts to employ these cellular 
functions in medicine for diagnosis and treatment, for example, by injecting specialized cells 
or implanting bioengineered cells in patients3,4. In this cell-based approach, it is desired and 
often necessary to communicate with these cells for receiving sensor signals from the cells 
or sending regulatory control signals to the cells. For this purpose, light offers an attractive 
means of communication in the biological system. Various light-sensitive molecules and 
genetic engineering tools are available to build optical interfaces into cells5,6. Fluorescent or 
bioluminescent proteins can be integrated into a specific pathway of endogenous sensing 
machinery for highly selective sensing7. Photoactive proteins, such as channel rhodopsin 
and melanopsin, can be coupled with the pathway leading to light-driven production of 
therapeutic substances with its timing and dose control by light8–11.
Despite the great promise of light-mediated, cell-based sensing and therapy, one of the 
fundamental challenges in this field is the high optical loss in biological tissue due to 
scattering and absorption12. The 1/e optical penetration depth, Le, at which the light 
intensity drops to 1/e level (37%), in soft tissue is less than 1 mm for the visible and near 
infrared range13. Transdermal light delivery by external illumination has shown to be viable 
for an optogenetic release of a therapeutic protein from the cells implanted subcutaneously 
in mice9. While this approach is feasible in small experimental animals through their thin 
skin, its application to humans is unlikely because it would require too high optical energy 
beyond the safety threshold (4 W/cm2) of the tissue. Endoscopes can provide minimally 
invasive access into the body. But this approach limits the location of cells to near the 
surfaces of internal organs, such as the mucosal layer of the gastrointestinal tracts, and is not 
suitable for continuous operation over an extended period of time (e.g. several days). 
Another challenge in this endeavor is the need to illuminate the implanted cells and collect 
light from them when the cells are dispersed widely in space. While a point illumination by 
an optical fiber is adequate for certain scenarios, such as focal optogenetic control in the 
brain14, most applications demand a sufficient number of cells distributed over dimensions 
much larger than the typical 1/e optical attenuation distance in order of 1 mm, for which 
point illumination by conventional optical fibers is not suited15.
Here, we demonstrate that hydrogels, which are commonly used as scaffolds for cell culture 
in vitro and implantation in vivo16, can be designed, fabricated, and used for efficient light 
delivery and collection, as well as cell encapsulation17,18. We show that cell-containing 
optical hydrogels can be implanted in vivo for an extended period and serve as an optical 
communication channel between encapsulated cells and an external light source and detector 
via a strand of thin flexible optical fiber (Fig. 1). We apply this novel approach to real-time 
Choi et al. Page 2
Nat Photonics. Author manuscript; available in PMC 2014 October 23.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tcell-based toxicity sensing and light-controlled optogenetic production of an anti-diabetic 
glucagon-like peptide-1 (GLP-1) in live mice.
Results
Polymer hydrogels has been extensively studied as cellular scaffolds. The porous aqueous 
polymeric network of hydrogels allows small molecules, such as glucose, oxygen, and 
secretory proteins, to be efficiently exchanged with surrounding host tissues by diffusion for 
the long-term survival of encapsulated cells. The cellular adhesiveness and biodegradability 
of hydrogels can be readily modified with the chemical compositions and fabrication 
parameters. The physicochemical, biomechanical, and biological properties of the hydrogels 
based on various synthetic or natural polymers have been characterized, and numerous 
recipes to optimize these properties have been established19,20. However, relatively little has 
been studied about the optimization of their optical properties. In the present study, we 
chose polyethylene glycol (PEG)-based hydrogels, widely used for various biomedical 
applications21. We began our study by finding optimal design parameters, such as molecular 
weights, water contents, and the shape of hydrogels, for desired functional properties. PEG-
based hydrogels were formed by UVinduced polymerization and crosslinking of PEG 
diacrylate (PEGDA) precursor solutions mixed with photoninitators (Irgacure, 0.05% w/v).
Optical transparency of PEG hydrogels
The ability to control the transparency of hydrogels is required for their photonic 
applications. To determine optimal compositions, we measured the optical loss spectra of 
hydrogels prepared by using PEGDA with various molecular weights (MW) of 0.5, 2, 5, and 
10 kDa, respectively, at the same concentration of 10% weight/volume (w/v) (Fig. 2a). PEG 
hydrogels with a MW of 0.5 kDa in standard 1-cm cuvettes were white opaque indicating 
strong uniform scattering across the visible spectrum. With increasing MW, PEG hydrogels 
became transparent. Attenuation spectroscopy confirmed the strong dependency on the MW 
of the precursor polymer. PEG hydrogels of 0.5 kDa had an optical loss of about 25 dB/cm 
(i.e. Le=1.8 mm) in the visible range (400–700 nm) (Fig. 2b). When the PEGDA 
concentration increased to 60% w/v or higher, hydrogels became noticeably more 
transparent (Supplementary Fig. S1). However, these concentrations were not adequate for 
cell encapsulation because of the low water contents (<90%). Furthermore, the hydrogels 
became increasingly stiffer with concentration, which can reduce cell viability and cause 
undesirable tissue damage when implanted in vivo. Hydrogels prepared with 2, 5, and 10 
kDa PEGDA exhibited much lower optical loss. In the blue to green range of 450–550 nm, 
the average loss was measured to be 0.68 dB/cm (Le=6.4 cm) for 2 kDa, 0.23 dB/cm (Le=19 
cm) for 5 kDa, and 0.17 dB/cm (Le=26 cm) for 10 kDa PEGDA. Hydrogels were fabricated 
in rectangular custom-made glass molds by in situ photo-induced crosslinking 
(Supplementary Fig. S2). The typical dimension of the PEG hydrogels was 4 mm in width, 1 
mm in height, and 10–40 mm in length. The fabricated 0.5-kDa hydrogels (10% w/v) were 
semi-opaque as seen through the 1-mm thickness, whereas the 5-kDa hydrogels were 
markedly more transparent (Fig. 2c).
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To investigate the stability of the optical properties of hydrogels in aqueous environment, 
we performed a swelling test. The hydrogels were immersed in phosphate buffered saline 
(PBS) for 12 h, and the fractional weight increase due to water absorption was measured22. 
The swelling ratio increased with the MW of PEGDA from 0.5 to 10 kDa (Fig. 2c). The 
rectangular shape of the 10-kDa hydrogels were found to be severely deformed due to 
swelling, whereas 0.5–5 kDa hydrogels maintained their rectangular shapes with minimal 
distortion. Interestingly, despite the swelling all hydrogels (0.5–10 kDa) did not show any 
apparent changes in transparency. We also found that hydrogels became more flexible with 
increasing MW. While 0.5 kDa hydrogels were quite brittle, 5 kDa hydrogels were highly 
elastic such that they could be easily bent and twisted (Fig. 2e). Considering the excellent 
transparency, structural stability, and mechanical flexibility, we chose to use PEG hydrogels 
with 5 kDa MW and 10% w/v concentration throughout the studies described below.
Light guiding in slab hydrogels
We investigated the optical guiding properties of slab hydrogels with a rectangular shape of 
4 mm (w) × 1 mm (h) × 40 mm (l). The refractive index of 10% w/v hydrogels was 
estimated to be about 1.35 (the index of 100% PEG is 1.465). When a laser beam (491 nm) 
was launched into the hydrogel at an angle, it propagated in a zigzag path (Fig. 2f) due to 
total internal reflection at the hydrogel-air interfaces. For fiber-optic connection, a 
multimode fiber (core diameter, 100 µm; numerical aperture, 0.37) was integrated during the 
fabrication of hydrogels (Supplementary Fig. S2). Light from an external light source was 
coupled into a hydrogel via the optical fiber pigtail (Fig. 3a). The light from the optical fiber 
was dispersed in the cross-section of the hydrogel nearly uniformly after a several-mm-long 
diffraction region (Fig. 3b). The light propagated all the way to the distal end of the 4 cm-
long hydrogel waveguide and exited through the end surface (Fig. 3b).
Light collection by hydrogels
We also tested the property of hydrogel waveguide for collecting the light that could be 
generated from a hydrogel or from the surrounding tissue and delivering it to a 
photodetector. We measured the amount of fluorescence light collected from a green-
fluorescent plate or dye solution (FITC; 5% w/v) at a varying distance, with and without a 
hydrogel in between (Fig. 3c). The excitation light (455 mm) was delivered from a laser 
through the pigtail fibers. The length of hydrogel was varied by cutting it from 40 mm to 30, 
20, 10 and 5 mm, respectively, in length (L). The collection efficiency of the optical fiber 
alone decreased with 1/L2, as expected from the geometry. On the other hand, with 
hydrogels the collection efficiency followed a linear decay function with 1/L (Fig. 3d). The 
difference in ratio, or the enhancement factor, increased linearly with the length of the 
hydrogel, which was about 80-fold (19 dB) for 4- cm-long hydrogels (Fig. 3e). Taken 
together, our results demonstrate the desired optical functions of the hydrogel both for 
transmitting light from an external source to the inside of the hydrogel and for delivering 
light from the hydrogel to an external detector.
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For cell encapsulation, Hela cells were mixed into the precursor PEGDA solution, with Arg-
Gly-Asp (RGD) peptides (1 mM), prior to crosslinking. Due to their refractive index profile 
(1.35–1.36 in the nucleus and 1.36–1.39 in cytoplasm23), the cells in the hydrogel refract 
and scatter light. Absorption spectroscopy showed the scattering-induced loss of cell-
encapsulated hydrogels (Fig. 3f). For a given cell density, the attenuation was relatively 
uniform over the visible to near infrared range (400–900 nm) with slight decreases with the 
wavelength. The attenuation coefficients were found to increase nonlinearly with the cell 
density (Fig. 3g), which reached as high as 2.4 dB/cm (Le=1.8 cm) with 5 × 106 cells/ml in 
the wavelength range of 450–500 nm. The cell density of about 106 cells/ml was determined 
to be optimal for 4-cm-long hydrogels, at which the loss is less than 1 dB/cm and the 1/e 
attenuation length (Le=5.6 cm) is comparable to the length of the hydrogel. At this cell 
density, a hydrogel with 1×4×40 mm3 (0.16 cm3) could contain up to 160,000 cells and, 
without molecular absorption, carry 70% light to its distal end.
Implantation of cell-containing hydrogel in vivo
Cell-containing hydrogels were implanted into the subcutaneous pocket of mice through a 1-
cm long skin incision on the back (Fig. 4a). The pigtail fiber was securely cemented onto the 
skull to establish stable light coupling to the hydrogel while the animal is awake and moving 
freely (Fig. 4b; Supplementary Video S1). Light leaked out of the hydrogel to the 
surrounding tissue could be readily monitored through the thin skin layer (Fig. 4c). The 
optical intensity throughout the entire implant varied no more than 6 dB, which is slightly 
higher than 1 dB/cm measured in the air and is due to the contact with the tissue (index, 
1.34–1.41) (Fig. 4d). By comparison, when only a multimode fiber was implanted without 
hydrogel, the 1/e light intensity was constrained to a small region with a diameter of 2–3 
mm as seen through the skin (Figs. 4c, d). This result represents a 40-fold increase of the 
illumination area by the light-guiding scaffold.
The hydrogels and surrounding tissues were harvested at day 3 and day 8 after implantation 
(n=3). Fluorescence microscopy with cell viability probes showed that about 80% of the 
embedded cells were found live in the hydrogels in vitro after photo-crosslinking, and more 
than 70% and 65% of the embedded cells in the implanted hydrogels remained viable for 3 
and 8 days, respectively (Fig. 4e), which was consistent with the measurement with 
hydrogels in a culture dish in vitro (Fig. 4f and Supplementary Fig. S3). The decreases of 
optical transmittance for 3 and 8 days in vitro and in vivo were less than 1 dB/cm (Fig. 4g). 
Histology suggested there were no major immune-cell infiltrations but the formation of 
connective tissues around the implants, which is a typical mild foreign body reaction, were 
observed in all, but not in shamsurgery, animals (Fig. 4i). The newly formed tissues were 
moderately vascularized. The hydrogel implants as a whole came off from the surrounding 
tissues so easily during tissue harvesting, indicating lack of adhesion between the tissues and 
hydrogels.
In vivo sensing of nanotoxicity
We applied fiber-optic cell-containing hydrogel implants for measurement of the toxicity of 
quantum-dot (Q-dot) in vivo. For sensing cellular toxicity, we employed an intrinsic cellular 
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tcytotoxicity sensor, heat-shock-protein 70 (hsp70)24, which is activated when cells are under 
cytotoxic stresses, such as heavy metal ions and reactive oxygen species, and green 
fluorescent protein (GFP) under the hsp77 promoter. Cadmium (Cd) is a widely used heavy 
metal in Q-dots but can cause cytotoxic effects when released by degradation of Q-dots. The 
magnitude of green fluorescence from these sensor cells in vitro increased with the sub-
lethal dose of CdCl2 up to 1 µM but saturated at higher concentrations of 1–5 µM 
(Supplementary Fig. S4). Two types of Cd-containing Q-dots were tested: core-only CdTe 
and core/shell CdSe/ZnS nanoparticles. The sizes of the bare and shelled Q-dots were about 
3.2 and 5.2 nm, respectively, such that they emit red fluorescence (605 nm) readily 
distinguishable from the green-fluorescence signal. When the cells were encapsulated in a 
hydrogel in vitro, the sensor signal increased with the concentration of CdTe Q-dots in the 
medium, but no noticeable change of green fluorescence was observed when CdSe/ZnS Q-
dots was applied (Fig. 5a, b). This result confirmed the dramatic role of the ZnS shell in 
reducing cellular toxicity.
Next, we implanted cell-encapsulating hydrogels into three groups of mice, which were 
treated by a systemic injection of CdTe Q-dots (100 pM), CdSe/ZnS Q-dots (100 pM), and 
PBS only, respectively. Time-lapse fiber-optic fluorescence measurement (Supplementary 
Fig. S5) showed significant increase in green fluorescence in the CdTe-treated group, but 
not in the CdSe/ZnS-treated and control groups, at day 1 and day 2 after the treatments (Fig. 
5c). To validate this measurement, we extracted the hydrogel implants at day 2 from the 
mice and examined with fluorescence microscopy (Fig. 5d). The total magnitude of GFP 
fluorescence from the cells was qualitatively consistent with the values measured in situ in 
live mice (Fig. 5e). These results represent the first real-time measurement of systemic 
cellular toxicity by Cd-based Q-dots and the effect of surface capping by biocompatible 
shells.
Optogenetic therapy of diabetic mice
To demonstrate cell-based therapy, we used a vector construct previously developed for 
optogenetic synthesis of GLP-19 and generated a stably transfected cell line (Supplementary 
Fig. S6). Upon absorption of blue light, the light-responsive protein, melanopsin, in the 
plasma membrane is activated, which increases intracellular calcium and consequently 
activates a transcription factor, nuclear factor of activated T cell (NFAT), which drives the 
production of GLP-1. GLP-1 is an anti-diabetic secretory protein that promotes glucose 
homeostasis by stimulating glucose-dependent insulin secretion25. We first confirmed the 
intended function of these optogenetic cells when encapsulated in a hydrogel in vitro. To 
monitor the change in the intracellular calcium level, the optogenetic cells were loaded with 
a fluorescence-based calcium indicator (OGB1-AM). More than 80% of the cells 
illuminated by blue light showed increase of intracellular calcium within several seconds 
(Fig. 6a, b). The temporal kinetics of calcium signals was consistent with cells in light-
exposed (ON) samples compared to non-illuminated (OFF) controls (Fig. 6c). This result 
confirmed the optogenetic synthesis of GLP-1 and permeability of secreted GLP-1 
molecules through the crosslinked hydrogel.
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cellcontaining hydrogel into chemically induced type-2 diabetic mice26. Blue light (455 nm, 
1 mW) was fiber-optically delivered for 12 h after the implantation. At 48 h after the 
implantation, lightexposed animals (n=4) showed approximately two-fold increase in the 
blood GLP-1 level compared to the non-illuminated control group (Fig. 6d). To validate 
physiological efficacy, we performed glucose tolerance test. Following an intraperitoneal 
injection of glucose (1.5 g/kg), the light-treated group achieved significantly improved 
glucose homeostasis where the blood glucose level returned to the initial level of 14 mM in 
90 min (Fig. 6e). In contrast, the blood glucose level of the non-treated group remained 
higher than 28 mM even after 120 min (Fig. 6e). This result demonstrates the therapeutic 
potential of the cell-hydrogel implant for optically controlled optogenetic synthesis in the 
body.
Discussion
Recently, there has been a growing interest to develop photonics devices based on 
biomaterials, such as silk fibroin27, agar17, and synthetic polymers28. Various biocompatible 
photonic components, such as optical fibers and gratings, have been demonstrated and their 
optical functions were tested under in vitro and, to some extent, in vivo settings. In this 
study, we have used PEG-based hydrogels to demonstrate, for the first time, in vivo 
biomedical applications of cell-containing optical waveguides. We have shown that 
hydrogels can serve not only as a cellular scaffold but also as a bidirectional optical 
communication channel for encapsulated cells. Optical hydrogel implants encapsulating 
cells with luminescent reporters and optogenetic gene-expression machinery allowed us to 
perform the first real-time sensing of nanotoxicity in animals and optogenetic diabetic 
therapy with an optical power of only 1 mW, much more efficient than conventional 
transdermal delivery9.
Optical transparency is essential for most photonic applications of hydrogels. We found that 
the longer PEGDA polymers yielded the higher transparency after crosslinking. This general 
tendency may be explained by the formation of pores in crosslinked hydrogels. In solutions 
prior to crosslinking, the precursor PEG chains are homogeneously dispersed in water and, 
therefore, transparent. UV-induced polymerization reorganizes the monomer distribution 
following energy minimization. This can introduce spatial inhomogeneity depending on the 
molecular compositions and crosslinking parameters. As a distinct phenomenon, phase 
separation between the polymer-rich phase and the water-rich phase29 can occur when the 
water content exceeds the maximum equilibrium level the crosslinked polymer can uptake 
during polymerization. The resulting pores, with sizes ranging from nano to micrometers, 
cause light scattering due to the refractive index contrast and reduces transparency. This 
mechanism explains the opaqueness of 0.5-kDa PEG hydrogels made at 10% w/v and the 
improved transparency at lower water contents (higher concentrations >15% w/v) 
(Supplementary Fig. S2).
The light guiding properties of hydrogels can be tailored for specific requirements by 
controlling the shape and structure of the hydrogels. For example, cell-based therapy in 
patients should require a sizable hydrogel to contain large number of cells to produce 
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tphysiologically relevant dose. In this case, an additional cladding layer with lower refractive 
index may be employed to enhance guiding. The width of the hydrogel may be tapered to 
compensate for cell-induced optical loss and, thereby, obtain more uniform optical intensity 
throughout the entire volume. Besides PEG, other polymers widely used in cell culture and 
tissue engineering, such as hyaluronic acid, alginate and collagen, are good candidates for 
optical hydrogels. Hydrogels based on these polymers have shown excellent properties for 
cell encapsulation. Compositional screening and optimization for optical characteristics 
could result in a range of material options for light-guiding hydrogels with different 
refractive indices. Other than a preformed hydrogel, injectable hydrogels such as thermo-
responsive gels may be used to facilitate minimally invasive implantation through in situ 
gelation30. Further optimization of mechanical stability, flexibility, or biodegradation is also 
achievable by modifying chemical compositions or fabrication protocol31. Additionally, 
photodegradable group may be introduced to control biodegradation kinetics.
There remain challenges for the clinical applications of hydrogels32. First, as the amount of 
therapeutic substances required for systemic diseases is proportional to the body weight, 
larger hydrogels are required. Our data indicate that it is plausible to increase the cell density 
by 5-fold (5 × 106 cells/cm3) without lowering the optical transmission substantially, and 
even higher concentrations may be possible with optimized hydrogel designs. Furthermore, 
different host cells with enhanced transfection efficiency may be used. For example, 
HEK293 cells have an order-of-magnitude higher protein production rate than the Hela cells 
used in our work9. Additionally, genetic and protein engineering to increase the production 
rate and stability of therapeutic protein will lead to a further reduced implant size33. Second, 
the cell-hydrogel implant should be functionally stable in vivo for several weeks and months 
depending on applications, for example, for chronic problems. Such long lifetime is 
currently challenging although not unattainable34. Lastly, more careful investigation of the 
long-term host response against implanted hydrogels is required35. All of the above issues 
have long been major research topics in the field of regenerative medicine and tissue 
engineering. Continuing progress in this field will increase the clinical potential of the 
hydrogel-based technique21.
The light-guiding hydrogel system can also employ non-cell-based chemical sensors and 
photoactive therapeutic molecules36. Although this approach does not benefit from the 
unique features, such as self-sustainability, of cells, it provides simplicity and allows 
existing molecular probes and drugs to be used in conjunction with light-guiding hydrogels.
In conclusion, we have demonstrated a new optical hydrogel waveguide, which offers 
excellent low-loss light-guiding properties and simultaneously meets all the requirements 
including long-term cell encapsulation, mechanical flexibility, and long-term transparency in 
vivo. By coupling the numerous cellular sensing and secretary protein-production pathways 
with optical readout and optogenetic signaling, the optical hydrogel system has a potential to 
be a platform technology with a broad range of applications in diagnosis and therapy.
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Hydrogel fabrication
PEGDA (Laysan Bio) solution in PBS at concentrations between 10 and 60% (w/v) was 
mixed with 0.05% (w/v) photoinitiator Irgacure 2959 (Ciba)22. The solution was transferred 
to a custom-made glass mold and exposed to a UV lamp (365 nm, 5 mW/cm2; Spectroline) 
for 15 min. For fiber coupling, a multimode optical fiber (100 µm-core, 0.37 NA; Doric 
Lenses) was embedded in the polymer solution at its tip (a few mm’s) and aligned to the 
long axis of the hydrogel prior to photo-crosslinking. Epoxy was applied to reinforce the 
fiber-hydrogel joint. For cell encapsulation, cells in culture dish were treated with trypsin, 
quantified and mixed into the PEGDA solution at concentration of 5 × 105 to 106 cells/ml 
prior to photo-crosslinking. The high cell-viability of this protocol was confirmed with 
multiple cell lines including Hela (human cervical cancer cell), HEK293T (human kidney 
cell), and EL4 (mouse T cell) (Supplementary Fig. S3). The crosslinked hydrogel was 
placed in culture medium and incubated for more than one day prior to implantation into a 
mouse. The cell medium was replaced at 1 h, 3 h, and every 24 h.
Preparation of cells
Hela cell (ATCC, Manassas, VA, USA) was maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum, and 1% antibiotics at 37 °C 
in 5% CO2. For cytotoxicity reporter cells, Hela cells were transiently transfected with an 
HSP70-GFP vector using Lipofectamine 2000 (Life Technologies) according to the 
manufacturer’s protocol. After incubation overnight, the cells were trypsinized and 
encapsulated in a hydrogel for the sensing experiments. Optogenetic cell line was generated 
by stable transfection of two vectors, namely pHY42 (human melanopsin; neomycin 
resistant) and pHY57 (NFAT-shGLP1, NFAT driven short variant human GLP1; 
hygromycin resistant). Hygromycin (150 mg/ml) and G418 (800 µg/ml) were added every 
other day from 48 h after introduction of the vectors for 2 weeks. Selected colonies were 
transferred into a 24 well plate and incubated. After being confluent, the cells dissolved in 
RIPA buffer containing 1% Triton- X100 and 0.1% SDS. The lysates were separated by a 
10% SDS-PAGE gel and transferred to a PVDF membrane. To check the expression level of 
melanopsin, the membrane was tested by western blot using polyclonal antibody against 
human melanopsin (ab65641, Abcam). Expression of shGLP-1 was confirmed by a GLP-1 
ELISA kit (Millipore). The cell lines that highly express both melanopsin and shGLP-1 were 
used for optogenetic experiments.
Characterization of hydrogels
PEG hydrogels were prepared in standard 1-cm-wide poly(methyl methacrylate) (PMMA) 
disposable cuvettes and optical attenuation was measured using a scanning 
spectrophotometer (Thermo Scientific). The optical transmittance of slab hydrogels was 
measured through their 1-mm thickness axes by using the collimated beam from a blue 
continuous-wave laser (20 mW, λ = 491 nm; Cobolt Calypso, Cobolt) and an optical power 
meter (1918-R, Newport). Swelling ratios, defined as the weight of dried hydrogel divided 
by the weight of hydrogel, were measured after placing hydrogels in PBS for 12 hours22. 
For cell viability test, a hydrogel was washed in serum-free medium and incubated in serum-
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tfree medium containing calcein AM (1 µl/ml; Life Technologies) and ethidium bromide (2 
µl/ml; Life Technologies) for 30 min. The hydrogel is then incubated in serum-free medium 
for 15 min, washed with PBS, and imaged with a fluorescence microscope (Olympus).
Implantation
After anesthetizing a mouse by intraperitoneal injection of ketamine (100 mg/kg) and 
xylazine (10 mg/kg), the dorsal skin was incised over about 1 cm horizontally, and a round 
spatula was inserted to form a subcutaneous pocket and then pulled out. The hydrogel was 
placed on the spatula and inserted together into the subcutaneous pocket. The spatula was 
slowly retracted, while the hydrogel remained inside. The incised skin was sutured using a 
6-0 nylon suture. For the fiber-connected hydrogel waveguide, a part of the scalp was 
incised and periosteum was retracted gently using Kimwipes. The optical fiber was fixed on 
the exposed skull by a drop of dental cement (GC Fuji I, GC America).
Histology
A full-thickness skin around the hydrogel implant was excised and fixed in 4% formalin for 
48 hours or longer. The skin sample is frozen-sectioned with 5-µm thickness and stained 
with hematoxylin and eosin (H&E). The slide was imaged with a bright-field microscope 
(Olympus) with a 10× objective lens.
Optical setup
A fiber-coupled light emitting diode (LED; λ = 455 nm; M455F1, Thorlabs) was coupled to 
a hydrogel through fluorescence detection cube with dichroic cutoff at 500 nm (Doric 
lenses), and emission was measured using a spectrometer (Andor). For optogenetic 
stimulation, the output of the fiber-coupled LED was modulated to 0.1 Hz rectangular pulses 
with 50% duty cycle (5 s on followed by 5 s off) by using a function generator. Optogenetic 
cells in culture were illuminated at an intensity of 0.5 mW/cm2 for 12 hours. To illuminate 
cells in the hydrogel waveguide implant, an average optical power of 1 mW was coupled 
into the pigtail fiber for 12 hours.
Preparation of Q-dots
CdTe quantum dot was synthesized in house via hydrothermal route by reacting Cd2+ with 
NaHTe solution37. For Cd2+ solution, 2.35 mM of Cd(ClO4)2·6H2O (Sigma) was dissolved 
in 125 mL of distilled water, mixed with 5.7 mM of thioglycolic acid (Sigma), and adjusted 
to a pH of 11.6. For NaHTe solution, 1.2 mM of Te powder and 6 mM of NaBH4 (Sigma) 
were reacted in a three-necked flask by adding 5 ml of N2 saturated distilled water. The flask 
was heated to 60 °C under nitrogen gas purging until the color of the solution turned white. 
The prepared solutions were mixed to form CdTe precursor solution. The precursor solution 
was heated to 100 °C until its fluorescence emission reached 600 nm, and then the solvent 
was exchanged to PBS through isopropanol precipitation. CdSe/ZnS quantum dot with 
amphiphilic coating was purchased from Life Technologies (Qdot-605, Q21301MP).
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For the in vitro study, the cytotoxicity reporter cells were treated with CdSe/ZnS or CdTe at 
one day after transfection. The change in GFP expression was measured at 24 h after the 
treatment. For the animal study, cell-encapsulating hydrogels were implanted into 8-week-
old Balb/c nude mice. One day after implantation, the baseline fluorescence was measured 
fiber-optically from the implant. Different groups of mice received intraperitoneal injections 
of PBS (100 µl), CdSe/ZnS (100 µl of 1 µM in PBS), and CdTe quantum dots (100 µl of 1 
µM in PBS), respectively. The fluorescence levels were measured at one and two days after 
the injection.
Glucose tolerance test
To test the therapeutic efficacy of optogenetically secreted GLP-1, we used a chemically 
induced type-2 diabetes model prepared by the administration of low dose streptozotocin26. 
Briefly, 8-week-old Balb/c nude mice were pre-starved for 4 hours and received 
streptozotocin (40 mg/kg) diluted in 0.1 M citrate buffer (pH 4.5) for 5 consecutive days. 
For 6 days, 10% sucrose solution was provided in drinking water to prevent hypoglycemia. 
After 2 weeks, blood glucose level was measured using a digital glucose meter (Fora), and 
the blood glucose level higher than 250 mg/dl was considered as a diabetic condition. For 
the glucose tolerance test, mice were starved for 6 hours, and the baseline glucose levels 
were measured. After administrating 1.5 g/kg of glucose intraperitoneally, the blood glucose 
levels were measured by titration at 15 min, 30 min, 60 min, 90 min and 120 min after the 
glucose injection. All animal experiments were performed in compliance with institutional 
guidelines and approved by the subcommittee on research animal care at the Massachusetts 
General Hospital.
Data analysis
ImageJ was used for image processing and data quantification. Data were expressed as the 
means ± SEM. Statistical analyses were performed using Graph Pad Prism software. 
Statistical differences were analyzed by t-test where indicated. P-value less than 0.05 was 
considered to be statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic of a light-guiding hydrogel encapsulating cells for in vivo sensing and therapy. 
The cells in the implanted hydrogel produce luminescence in response to environmental 
stimuli (sensing) and secrete cytokines and hormones upon photo-activation (therapy). The 
light guiding hydrogel establishes a bi-directional optical communications with the cells, 
allowing real-time interrogation and control of the biological system in vivo.
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Characteristics of hydrogels. (a) Photographs of PEG-based hydrogels prepared by using 
10% w/v PEGDA solution with different MW’s of 0.5, 2, 5, and 10 kDa, respectively. Scale 
bar, 1 cm. (b) The optical attenuation spectra of PEG hydrogels prepared with different 
MW’s of PEGDA. (c) Rectangular-shaped 0.5- and 5-kDa hydrogels with a thickness of 1 
mm. Scale bar, 5 mm. (d) Swelling ratios of PEG hydrogels. The swelling ratio was 
calculated by dividing weight of swollen hydrogel by weight of dried hydrogel (n = 3). (e) 
Mechanical flexibility of the PEG hydrogel (5 kDa, 10%). (f) Demonstration of total internal 
reflection within the slab hydrogel.
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Light-guiding properties of fiber-optic hydrogels. (a) A setup for coupling light into a 
hydrogel waveguide via a multimode fiber. (b) Photographs showing light coupling to a 
hydrogel Top, a hydrogel before light coupling; middle, a hydrogel after light coupling; and 
bottom, a pseudo color image for spatial profile of scattered light. (c) Schematic of the setup 
for measuring the collection efficiency. A fluorescent sample (green) was placed in contact 
with hydrogels with varying lengths (left) or at the equivalent distances from a multimode 
fiber (right). (d) Magnitude of fluorescence collected into the optical fibers with and without 
the hydrogels. Dashed lines, curve fit with 1/L2 and 1/L dependence for the hydrogel and 
optical fiber alone, respectively. (e) The ratio of fluorescence with and without the 
hydrogels. The dashed line represents a linear regression (R2 = 0.98). (f) The optical 
attenuation spectra of the hydrogels at various cellular density levels. Inset shows a phase-
contrast micrograph of the hydrogel. Scale bar, 50 µm. (g) Average optical attenuation of a 
hydrogel with 1 × 106 cells/cm3 in a spectral range of 450–500 nm. The dashed line shows 
an exponential fit (R2 = 0.96).
Choi et al. Page 16
Nat Photonics. Author manuscript; available in PMC 2014 October 23.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 4. 
Hydrogel implants in vivo. (a) Schematic of a fiber-pigtailed hydrogel waveguide implanted 
in a mouse. (b) A hydrogel-implanted mouse in a freely moving state. Blue light (491 nm) 
was coupled. (c) Photographs showing the light scattering profiles from an optical hydrogel 
implant (left) and from an optical fiber (right). (d) Axial profiles of the magnitude of 
scattered light from the hydrogel implant (blue) and the optical fiber only (black). (e) 
Fluorescence images of hydrogel implants immediately after taken out of mice at 3 days and 
8 days after implantation, in comparison to control (Day 0; prior to implantation). Live cells 
emit green fluorescence from a membrane-permeable live-cell staining dye, calcein-AM, 
and dead cells are identified by red fluorescence from ethidium bromide in the cell nuclei. 
Scale bar, 50 µm. (f) Long-term viability of the encapsulated cells in vivo. Error bars are 
standard deviations (n = 6 each). (g) Change in optical transmittance of the hydrogel 
implants in vivo. (h) H&E histology images of the skin tissues examined at 8 days after 
implantation, showing (i) dermis, (ii) panniculus carnosus, (iii) subcutaneous loose 
connective tissue layer, (iv) newly formed connective tissue layer. In the magnified image 
(right), arrows indicate red blood cells in blood vessels. Scale bar, 100 µm.
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Cell-based sensing of nano-cytotoxicity of quantum dots. (a,b) Fluorescence images of the 
sensor cells in hydrogels in vitro at two days after adding CdTe and CdSe/ZnS Q-dots, 
respectively, into the medium. Scale bar, 20 µm. (b) The magnitude of green fluorescence 
from the hydrogels, measured through the pigtail fibers. (c) In vivo measurement of the 
fluorescence signals from the sensing cells in hydrogels implanted in live mice. Q-dots were 
administered by intravenous injection 24 hours after the hydrogels were implanted. (d) 
Fluorescence images of the hydrogels extracted from the mouse at day 3. Scale bar, 20 µm. 
(e) Comparison of the GFP fluorescence measured fiber-optically in vivo (left) and 
fluorescence microscopy ex vivo (right).
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Optogenetic therapy in a mouse model of diabetes. (a) Fluorescence calcium-level imaging 
of optogenetic cells in a hydrogel waveguide in vitro. Upon delivering blue light (455 nm) 
through the fiber for 10 s at 1 mW, the fluorescence from an intracellular calcium indicator, 
OGB1-AM increased significantly. Scale bar, 20 µm. (b) Time traces of intracellular 
calcium signals from various cells marked in (a). (c) Concentrations of active GLP-1 in the 
medium of hydrogels with (ON) and without (OFF) providing the activation light. (d) Level 
of GLP-1 in blood plasma measured in vivo at 2 days after light exposure. (e) Blood glucose 
levels in the chemically induced diabetic mice with and without delivering activation light. 
Error bars, standard deviations (n = 4).
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